Epidermal stem cell RAB23 gene knockout through CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR-associated proteins) system
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 浙江玉安康瑞生物科技有限公司
- Publication Date
- 2018-11-27
Smart Images

Figure 1
Abstract
Description
technical field
[0001] The present invention provides a CRISPR-Cas system for RAB23 gene editing on epidermal stem cells, and in particular relates to the establishment of a RAB23 knockout epidermal stem cell line. Background technique
[0002] Epidermal stem cells (Epidermal stem cells, EpiSCS) are stem cells with self-proliferation and multi-lineage differentiation potential. Its normal proliferation and differentiation are the basic requirements for maintaining the structural and functional integrity of the skin and its appendages (sweat glands, hair, sebaceous glands). Under physiological conditions, epidermal stem cells differentiate into a stem cell and a transit amplifying cell (TA cell) through asymmetric division, and the TA cell differentiates into post-mitotic cells (Post-mitotic cells) and terminal cells after multiple divisions. Differentiated cells (terminally-differentiated cells) to supplement the continuous renewal of epidermal cells. Studies have shown tha...